Debt-to-equity of NIKA PHARMACEUTICALS, INC from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NIKA PHARMACEUTICALS, INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • NIKA PHARMACEUTICALS, INC Debt-to-equity for the quarter ending 30 Sep 2025 was -111%, a 34% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NIKA PHARMACEUTICALS, INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -111% +59% +34% 30 Sep 2025
Q2 2025 -110% +74% +40% 30 Jun 2025
Q1 2025 -157% -38% -32% 31 Mar 2025
Q4 2024 -158% -40% -34% 31 Dec 2024
Q3 2024 -170% -56% -49% 30 Sep 2024
Q2 2024 -185% -68% -58% 30 Jun 2024
Q1 2024 -119% +15% +11% 31 Mar 2024
Q4 2023 -118% 31 Dec 2023
Q3 2023 -114% 30 Sep 2023
Q2 2023 -117% 30 Jun 2023
Q1 2023 -134% 31 Mar 2023
Q4 2021 -105% 31 Dec 2021
Q3 2021 -108% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.